181 related articles for article (PubMed ID: 18828071)
1. Clinical Research in Emerging Countries--Third Annual Marcus Evans Conference.
Singh S
IDrugs; 2008 Oct; 11(10):724-7. PubMed ID: 18828071
[No Abstract] [Full Text] [Related]
2. Emerging trends in contract research industry in India.
Drabu S; Gupta A; Bhadauria A
Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
[TBL] [Abstract][Full Text] [Related]
3. India's growing participation in global clinical trials.
Gupta YK; Padhy BM
Trends Pharmacol Sci; 2011 Jun; 32(6):327-9. PubMed ID: 21489644
[TBL] [Abstract][Full Text] [Related]
4. Impact of cancer research bureaucracy on innovation, costs, and patient care.
Steensma DP; Kantarjian HM
J Clin Oncol; 2014 Feb; 32(5):376-8. PubMed ID: 24395852
[No Abstract] [Full Text] [Related]
5. India's amended trials regulations spark research exodus.
Shukla S
Lancet; 2013 Sep; 382(9895):845. PubMed ID: 24020066
[No Abstract] [Full Text] [Related]
6. Latin American science moves into the spotlight.
Triunfol ML
Cell; 2007 Dec; 131(7):1213-6. PubMed ID: 18160028
[TBL] [Abstract][Full Text] [Related]
7. Justice in the application of science: beyond fair benefits.
London AJ
Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
[No Abstract] [Full Text] [Related]
8. Response to open peer commentaries on "How to do research fairly in an unjust world".
Ballantyne AJ
Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
[No Abstract] [Full Text] [Related]
9. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
10. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
11. Disparate compensation policies for research related injury in an era of multinational trials: a case study of Brazil, Russia, India, China and South Africa.
Chingarande GR; Moodley K
BMC Med Ethics; 2018 Feb; 19(1):8. PubMed ID: 29454351
[TBL] [Abstract][Full Text] [Related]
12. Regulating the market in human research participants.
Lemmens T; Miller PB
PLoS Med; 2006 Aug; 3(8):e330. PubMed ID: 16866575
[TBL] [Abstract][Full Text] [Related]
13. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.
Farrell K
J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228
[No Abstract] [Full Text] [Related]
14. Guidance on financial disclosure requirements.
Maloney DM
Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833562
[No Abstract] [Full Text] [Related]
15. Task force ready on financial conflict of interest in research.
Maloney DM
Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833561
[No Abstract] [Full Text] [Related]
16. [New European rules for clinical trials competition-promoting for Sweden...can we keep the advantage?].
Strandberg K
Lakartidningen; 2005 Mar 21-Apr 3; 102(12-13):962-5. PubMed ID: 15887643
[No Abstract] [Full Text] [Related]
17. Fair benefits in developing countries: maximin as a good start.
Macklin R
Am J Bioeth; 2010 Jun; 10(6):36-7. PubMed ID: 20526967
[No Abstract] [Full Text] [Related]
18. Multiple forms of exploitation in international research: the need for multiple standards of fairness.
Snyder J
Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969
[No Abstract] [Full Text] [Related]
19. Leaders worry that U.S. is losing edge on cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
[No Abstract] [Full Text] [Related]
20. [Conflict of interest in clinical research--trends in guidelines for research ethics in Japan and other countries].
Tashiro M
Seishin Shinkeigaku Zasshi; 2010; 112(11):1130-5. PubMed ID: 21351693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
